Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions

RemimazolamEmergence DeliriumRhinoplasty

Interventions

DRUG

Remimazolam 20 MG Injection [Byfavo]

Remimazolam 0.1 mg/kg intravenous injection

DRUG

NaCl 0.9%

NaCl 0.9% 0.04 mL/kg

Trial Locations (1)

RECRUITING

UH Split, Split

All Listed Sponsors

lead

University Hospital of Split

OTHER